Skip to main content
. 2013 Mar 8;8(3):e58544. doi: 10.1371/journal.pone.0058544

Figure 2. High peripheral blood myeloid chimerisms in busulfan-treated chimeras.

Figure 2

A) Representative FACS dot plots showing the expression of GFP in blood granulocytes, monocytes, B cells and T cells of busulfan-treated and irradiated CX3CR1GFP/+ → CX3CR1+/+ chimeras and untreated mice four weeks after bone marrow transfer. Percentages of the respective cell populations are indicated. CX3CR1+/+ mice served as untreated controls. B) Quantitative assessment of GFP+ expression in overall monocytes (SSCloCD11b+) and the two monocyte subsets SSCloCD11b+Ly6Chi and SSCloCD11b+Ly6Clo out of all SSCloCD11b+ cells. Data depict high reconstitution efficiencies and comparable chimerisms in both groups. One symbol represents one mouse (Busulfan-treated: filled circle; irradiated: filled squares). Mean ± SEM are shown. Six to seven animals per group were analysed. C) Photograph showing change of fur color 16 weeks after treatment. Irradiation leads to a loss of fur color, whereas busulfan-treated animals remain unaffected. Top: untreated animal, middle: whole-body irradiated animal, bottom: busulfan-treated mouse.